LATEST
NEWS

The FDA rejects celiprolol - how should we interpret the news?

NEW STUDY: vEDS patients are living longer, but unclear what role celiprolol plays

Longer Life with vEDS: A Lesson from Marfan Syndrome

The 4 Essential Elements of your vEDS Care Team

The University of Washington and FIGHT vEDS ask patients to set the research agenda

Congress Attempts to Alter the Orphan Drug Tax Credit

5 Tips from Benjamin Franklin for vascular EDS

Acer Therapeutics Obtains Exclusive License to Celiprolol Study Data